Outcomes after switching from one bisphosphonate to another in 146 patients at a single university hospital View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-05-06

AUTHORS

H. Ideguchi, S. Ohno, K. Takase, A. Ueda, Y. Ishigatsubo

ABSTRACT

Most patients who switched to a second bisphosphonate continued their treatment long term, although those who stopped their first drug because of adverse events were likely to discontinue the second drug for the same reason. Switching to another bisphosphonate is a reasonable treatment option for some patients with treatment failure.IntroductionPatients who experience treatment failure with a bisphosphonate because of adverse events (AEs) or other reasons might receive a second bisphosphonate. However, the frequency and benefits of switching bisphosphonates are unknown.MethodsWe retrospectively evaluated 197 men and 1110 women newly treated with bisphosphonates between 1 January 2000 and 30 June 2005 at our university hospital.ResultsAmong the 497 patients who discontinued bisphosphonate treatment, 146 were switched to a second bisphosphonate. The cumulative probabilities of persistence of treatment after 3 years were 45% with the first bisphosphonate and 65% with the second (P = 0.017). Age ≥65 years, switching bisphosphonates because of AEs, and male gender were associated (P < 0.05) with low persistence of treatment with the second bisphosphonate. Discontinuation of the first drug because of AEs was associated with an increased rate of discontinuation of the second drug because of AEs (hazard ratio, 4.2; 95% confidence interval, 2.1–8.4).ConclusionsPatients who switched bisphosphonates had high rates of persistence of therapy. Those who stopped their first bisphosphonate because of AEs were at risk of discontinuing the second drug for the same reason. Switching to another bisphosphonate is a reasonable treatment option for some patients with treatment failure. More... »

PAGES

1777-1783

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00198-008-0618-y

DOI

http://dx.doi.org/10.1007/s00198-008-0618-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1051031077

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18458987


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Density Conservation Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diphosphonates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medication Adherence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteoporosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Compliance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ideguchi", 
        "givenName": "H.", 
        "id": "sg:person.01324761473.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324761473.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohno", 
        "givenName": "S.", 
        "id": "sg:person.013722512012.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013722512012.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan", 
          "id": "http://www.grid.ac/institutes/grid.413045.7", 
          "name": [
            "Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takase", 
        "givenName": "K.", 
        "id": "sg:person.0756602733.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756602733.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.268441.d", 
          "name": [
            "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ueda", 
        "givenName": "A.", 
        "id": "sg:person.01032032373.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032032373.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan", 
          "id": "http://www.grid.ac/institutes/grid.268441.d", 
          "name": [
            "Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ishigatsubo", 
        "givenName": "Y.", 
        "id": "sg:person.01125133646.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125133646.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00198-007-0406-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013678762", 
          "https://doi.org/10.1007/s00198-007-0406-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001980070064", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042388661", 
          "https://doi.org/10.1007/s001980070064"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00774-004-0509-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010011368", 
          "https://doi.org/10.1007/s00774-004-0509-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-006-0136-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031571579", 
          "https://doi.org/10.1007/s00198-006-0136-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-006-0322-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012288373", 
          "https://doi.org/10.1007/s00198-006-0322-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001980200135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033038209", 
          "https://doi.org/10.1007/s001980200135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-006-0179-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038026469", 
          "https://doi.org/10.1007/s00198-006-0179-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-006-0294-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002840519", 
          "https://doi.org/10.1007/s00198-006-0294-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-05-06", 
    "datePublishedReg": "2008-05-06", 
    "description": "Most patients who switched to a second bisphosphonate continued their treatment long term, although those who stopped their first drug because of adverse events were likely to discontinue the second drug for the same reason. Switching to another bisphosphonate is a reasonable treatment option for some patients with treatment failure.IntroductionPatients who experience treatment failure with a bisphosphonate because of adverse events (AEs) or other reasons might receive a second bisphosphonate. However, the frequency and benefits of switching bisphosphonates are unknown.MethodsWe retrospectively evaluated 197 men and 1110 women newly treated with bisphosphonates between 1 January 2000 and 30 June 2005 at our university hospital.ResultsAmong the 497 patients who discontinued bisphosphonate treatment, 146 were switched to a second bisphosphonate. The cumulative probabilities of persistence of treatment after 3\u00a0years were 45% with the first bisphosphonate and 65% with the second (P\u2009=\u20090.017). Age \u226565\u00a0years, switching bisphosphonates because of AEs, and male gender were associated (P\u2009<\u20090.05) with low persistence of treatment with the second bisphosphonate. Discontinuation of the first drug because of AEs was associated with an increased rate of discontinuation of the second drug because of AEs (hazard ratio, 4.2; 95% confidence interval, 2.1\u20138.4).ConclusionsPatients who switched bisphosphonates had high rates of persistence of therapy. Those who stopped their first bisphosphonate because of AEs were at risk of discontinuing the second drug for the same reason. Switching to another bisphosphonate is a reasonable treatment option for some patients with treatment failure.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00198-008-0618-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100834", 
        "issn": [
          "0937-941X", 
          "1433-2965"
        ], 
        "name": "Osteoporosis International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "adverse events", 
      "reasonable treatment option", 
      "treatment failure", 
      "second drug", 
      "first bisphosphonate", 
      "treatment options", 
      "University Hospital", 
      "first drug", 
      "treatment long term", 
      "rate of discontinuation", 
      "single university hospital", 
      "bisphosphonate treatment", 
      "most patients", 
      "male gender", 
      "bisphosphonates", 
      "patients", 
      "cumulative probability", 
      "drugs", 
      "discontinuation", 
      "hospital", 
      "high rate", 
      "treatment", 
      "failure", 
      "long term", 
      "IntroductionPatients", 
      "ConclusionsPatients", 
      "ResultsAmong", 
      "options", 
      "therapy", 
      "years", 
      "MethodsWe", 
      "women", 
      "persistence", 
      "age", 
      "outcomes", 
      "men", 
      "risk", 
      "rate", 
      "low persistence", 
      "events", 
      "gender", 
      "reasons", 
      "same reason", 
      "benefits", 
      "frequency", 
      "probability", 
      "terms"
    ], 
    "name": "Outcomes after switching from one bisphosphonate to another in 146 patients at a single university hospital", 
    "pagination": "1777-1783", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1051031077"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00198-008-0618-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18458987"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00198-008-0618-y", 
      "https://app.dimensions.ai/details/publication/pub.1051031077"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_453.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00198-008-0618-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-008-0618-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-008-0618-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-008-0618-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-008-0618-y'


 

This table displays all metadata directly associated to this object as RDF triples.

248 TRIPLES      22 PREDICATES      100 URIs      84 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00198-008-0618-y schema:about N2aad505d4ff84264a6fdd3a5e1af893d
2 N2d5f9e66d5c6432d92662b727555f780
3 N3acda351a2574f1289b46ce73aab8cde
4 N40f0018492d34a0aba4fc907d010bf4e
5 N44453d30eeb04d0a99e5068ae89c2cbb
6 N51049321f4354389a97b2ad039281ab9
7 N7122bfd02f5d4cae888088d83a1e6514
8 N7995b8e926e941478b3e6780124feaf8
9 N98fa27cfb5c34040b7d4de9dd1113f9a
10 Nb77c63b2de02440bb35c46c3947612cd
11 Nc1637cf252bd45a0b70835262c3d3c74
12 Nca17bfc1cdd849e19688ea8ed01e6fb2
13 Ncb6ac2e324d34547af42fcadbcc5dbfe
14 Nd1ccd6bf2d0a40e9b38a49b1a547761e
15 Ndbbc718e5ef543d2a7e0866a0ec1f9c7
16 Ne341d9bea7f548a1a1c764acfb05640b
17 Ne53ecbb98adf43878476b8b8e7cbdd8f
18 Necee5fd851974411885f999225b5a85a
19 Ned039c82bdbd406dbb3db4d343cdb847
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N92e3e7e0cd714b37a0f8f1040c84808a
23 schema:citation sg:pub.10.1007/s00198-006-0136-8
24 sg:pub.10.1007/s00198-006-0179-x
25 sg:pub.10.1007/s00198-006-0294-8
26 sg:pub.10.1007/s00198-006-0322-8
27 sg:pub.10.1007/s00198-007-0406-0
28 sg:pub.10.1007/s001980070064
29 sg:pub.10.1007/s001980200135
30 sg:pub.10.1007/s00774-004-0509-z
31 schema:datePublished 2008-05-06
32 schema:datePublishedReg 2008-05-06
33 schema:description Most patients who switched to a second bisphosphonate continued their treatment long term, although those who stopped their first drug because of adverse events were likely to discontinue the second drug for the same reason. Switching to another bisphosphonate is a reasonable treatment option for some patients with treatment failure.IntroductionPatients who experience treatment failure with a bisphosphonate because of adverse events (AEs) or other reasons might receive a second bisphosphonate. However, the frequency and benefits of switching bisphosphonates are unknown.MethodsWe retrospectively evaluated 197 men and 1110 women newly treated with bisphosphonates between 1 January 2000 and 30 June 2005 at our university hospital.ResultsAmong the 497 patients who discontinued bisphosphonate treatment, 146 were switched to a second bisphosphonate. The cumulative probabilities of persistence of treatment after 3 years were 45% with the first bisphosphonate and 65% with the second (P = 0.017). Age ≥65 years, switching bisphosphonates because of AEs, and male gender were associated (P < 0.05) with low persistence of treatment with the second bisphosphonate. Discontinuation of the first drug because of AEs was associated with an increased rate of discontinuation of the second drug because of AEs (hazard ratio, 4.2; 95% confidence interval, 2.1–8.4).ConclusionsPatients who switched bisphosphonates had high rates of persistence of therapy. Those who stopped their first bisphosphonate because of AEs were at risk of discontinuing the second drug for the same reason. Switching to another bisphosphonate is a reasonable treatment option for some patients with treatment failure.
34 schema:genre article
35 schema:inLanguage en
36 schema:isAccessibleForFree false
37 schema:isPartOf N2c246dafd0004266a6db46969cf049af
38 N89c569cd701d4934a1c670f8065ea136
39 sg:journal.1100834
40 schema:keywords ConclusionsPatients
41 IntroductionPatients
42 MethodsWe
43 ResultsAmong
44 University Hospital
45 adverse events
46 age
47 benefits
48 bisphosphonate treatment
49 bisphosphonates
50 cumulative probability
51 discontinuation
52 drugs
53 events
54 failure
55 first bisphosphonate
56 first drug
57 frequency
58 gender
59 high rate
60 hospital
61 long term
62 low persistence
63 male gender
64 men
65 most patients
66 options
67 outcomes
68 patients
69 persistence
70 probability
71 rate
72 rate of discontinuation
73 reasonable treatment option
74 reasons
75 risk
76 same reason
77 second drug
78 single university hospital
79 terms
80 therapy
81 treatment
82 treatment failure
83 treatment long term
84 treatment options
85 women
86 years
87 schema:name Outcomes after switching from one bisphosphonate to another in 146 patients at a single university hospital
88 schema:pagination 1777-1783
89 schema:productId N8bd1575495f54fe7a111834285389720
90 Nbcaa5b13db474134817e30c78acaa4ae
91 Nf034a19b31bd4d57a625ecfc99e17b0b
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051031077
93 https://doi.org/10.1007/s00198-008-0618-y
94 schema:sdDatePublished 2022-05-20T07:24
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher N3eda3141f766433683188bff78360f50
97 schema:url https://doi.org/10.1007/s00198-008-0618-y
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N03b31dc7bbaf485c985aa3a01201a91b rdf:first sg:person.01032032373.04
102 rdf:rest Nd6dcd027f5104562bf6d87076f0b0333
103 N2aad505d4ff84264a6fdd3a5e1af893d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Risk Assessment
105 rdf:type schema:DefinedTerm
106 N2c246dafd0004266a6db46969cf049af schema:volumeNumber 19
107 rdf:type schema:PublicationVolume
108 N2d5f9e66d5c6432d92662b727555f780 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Aged, 80 and over
110 rdf:type schema:DefinedTerm
111 N3acda351a2574f1289b46ce73aab8cde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Gastrointestinal Diseases
113 rdf:type schema:DefinedTerm
114 N3eda3141f766433683188bff78360f50 schema:name Springer Nature - SN SciGraph project
115 rdf:type schema:Organization
116 N40f0018492d34a0aba4fc907d010bf4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Adolescent
118 rdf:type schema:DefinedTerm
119 N44453d30eeb04d0a99e5068ae89c2cbb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Medication Adherence
121 rdf:type schema:DefinedTerm
122 N51049321f4354389a97b2ad039281ab9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Osteoporosis
124 rdf:type schema:DefinedTerm
125 N7122bfd02f5d4cae888088d83a1e6514 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 N7995b8e926e941478b3e6780124feaf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Young Adult
130 rdf:type schema:DefinedTerm
131 N83f295e7159045c7b1dc3a123ec892d8 rdf:first sg:person.013722512012.55
132 rdf:rest Na6aeb9faf140430ea20ed6a6fb84739d
133 N89c569cd701d4934a1c670f8065ea136 schema:issueNumber 12
134 rdf:type schema:PublicationIssue
135 N8bd1575495f54fe7a111834285389720 schema:name doi
136 schema:value 10.1007/s00198-008-0618-y
137 rdf:type schema:PropertyValue
138 N92e3e7e0cd714b37a0f8f1040c84808a rdf:first sg:person.01324761473.79
139 rdf:rest N83f295e7159045c7b1dc3a123ec892d8
140 N98fa27cfb5c34040b7d4de9dd1113f9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Treatment Outcome
142 rdf:type schema:DefinedTerm
143 Na6aeb9faf140430ea20ed6a6fb84739d rdf:first sg:person.0756602733.05
144 rdf:rest N03b31dc7bbaf485c985aa3a01201a91b
145 Nb77c63b2de02440bb35c46c3947612cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Middle Aged
147 rdf:type schema:DefinedTerm
148 Nbcaa5b13db474134817e30c78acaa4ae schema:name pubmed_id
149 schema:value 18458987
150 rdf:type schema:PropertyValue
151 Nc1637cf252bd45a0b70835262c3d3c74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Diphosphonates
153 rdf:type schema:DefinedTerm
154 Nca17bfc1cdd849e19688ea8ed01e6fb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Adult
156 rdf:type schema:DefinedTerm
157 Ncb6ac2e324d34547af42fcadbcc5dbfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Bone Density Conservation Agents
159 rdf:type schema:DefinedTerm
160 Nd1ccd6bf2d0a40e9b38a49b1a547761e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Retrospective Studies
162 rdf:type schema:DefinedTerm
163 Nd6dcd027f5104562bf6d87076f0b0333 rdf:first sg:person.01125133646.44
164 rdf:rest rdf:nil
165 Ndbbc718e5ef543d2a7e0866a0ec1f9c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Patient Compliance
167 rdf:type schema:DefinedTerm
168 Ne341d9bea7f548a1a1c764acfb05640b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Male
170 rdf:type schema:DefinedTerm
171 Ne53ecbb98adf43878476b8b8e7cbdd8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Drug Administration Schedule
173 rdf:type schema:DefinedTerm
174 Necee5fd851974411885f999225b5a85a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Aged
176 rdf:type schema:DefinedTerm
177 Ned039c82bdbd406dbb3db4d343cdb847 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Female
179 rdf:type schema:DefinedTerm
180 Nf034a19b31bd4d57a625ecfc99e17b0b schema:name dimensions_id
181 schema:value pub.1051031077
182 rdf:type schema:PropertyValue
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
187 schema:name Clinical Sciences
188 rdf:type schema:DefinedTerm
189 sg:journal.1100834 schema:issn 0937-941X
190 1433-2965
191 schema:name Osteoporosis International
192 schema:publisher Springer Nature
193 rdf:type schema:Periodical
194 sg:person.01032032373.04 schema:affiliation grid-institutes:grid.268441.d
195 schema:familyName Ueda
196 schema:givenName A.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032032373.04
198 rdf:type schema:Person
199 sg:person.01125133646.44 schema:affiliation grid-institutes:grid.268441.d
200 schema:familyName Ishigatsubo
201 schema:givenName Y.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125133646.44
203 rdf:type schema:Person
204 sg:person.01324761473.79 schema:affiliation grid-institutes:grid.413045.7
205 schema:familyName Ideguchi
206 schema:givenName H.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324761473.79
208 rdf:type schema:Person
209 sg:person.013722512012.55 schema:affiliation grid-institutes:grid.413045.7
210 schema:familyName Ohno
211 schema:givenName S.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013722512012.55
213 rdf:type schema:Person
214 sg:person.0756602733.05 schema:affiliation grid-institutes:grid.413045.7
215 schema:familyName Takase
216 schema:givenName K.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756602733.05
218 rdf:type schema:Person
219 sg:pub.10.1007/s00198-006-0136-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031571579
220 https://doi.org/10.1007/s00198-006-0136-8
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s00198-006-0179-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038026469
223 https://doi.org/10.1007/s00198-006-0179-x
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s00198-006-0294-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002840519
226 https://doi.org/10.1007/s00198-006-0294-8
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/s00198-006-0322-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012288373
229 https://doi.org/10.1007/s00198-006-0322-8
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/s00198-007-0406-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013678762
232 https://doi.org/10.1007/s00198-007-0406-0
233 rdf:type schema:CreativeWork
234 sg:pub.10.1007/s001980070064 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042388661
235 https://doi.org/10.1007/s001980070064
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s001980200135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033038209
238 https://doi.org/10.1007/s001980200135
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s00774-004-0509-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1010011368
241 https://doi.org/10.1007/s00774-004-0509-z
242 rdf:type schema:CreativeWork
243 grid-institutes:grid.268441.d schema:alternateName Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
244 schema:name Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
245 rdf:type schema:Organization
246 grid-institutes:grid.413045.7 schema:alternateName Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan
247 schema:name Center for Rheumatic Diseases, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, 232-0024, Yokohama, Kanagawa, Japan
248 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...